Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GC Pharma Reports Q1 2019 Results
2019-04-30 15:37
New Research Partnership Brings Top-Class Scientists to China to Tackle Biomedical Problems
2019-04-26 18:33
Specialisterne Foundation and Brunel Enable Autistic People to Join the Workforce
2019-04-25 09:00
HEC TaiGen Initiates Phase III Trial of Combination of Furaprevir and Yimitasvir for the Treatment of Chronic Hepatitis C Patients in China
2019-04-23 15:58
ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan
2019-04-19 12:00
Senhwa Biosciences Silmitasertib / Basal Cell Carcinoma Trial Completed 1st Patient Enrollment
2019-04-17 19:00
Wuhan Lays Out Construction of Guanggu Nanda Health Industrial Park
2019-04-12 14:06
I-Mab Biopharma Signs Agreement for Clinical Research of TJD5 in Combination Therapy
2019-04-11 10:34
Antengene Corporation Announces Establishment of U.S. Subsidiary and Collaboration with the Baruch S. Blumberg Institute
2019-04-08 20:00
WuXi AppTec Appoints Dr. Frederick H. Hausheer as Chief Medical Officer
2019-04-08 10:00
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection
2019-03-27 14:00
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board
2019-03-26 08:30
WuXi AppTec Reports Strong 2018 Annual Results
2019-03-22 20:47
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials
2019-03-21 18:21
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row
2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
2019-03-21 07:20
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma
2019-03-20 05:05
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
2019-03-18 23:58
Transcenta Holding announces appointment of Dr. Yi Gu as Senior Vice President and Head of Research
2019-03-11 22:30
WuXi AppTec Testing Facilities Complete Three Regulatory Inspections from US FDA, OECD, and CNAS with Excellent Results
2019-03-11 16:00
1
129
130
131
132
133
220